TED R
Alternative Names: TED-R; TED-R - S.BiomedicsLatest Information Update: 30 Jun 2023
At a glance
- Originator S.Biomedics
- Class Neural stem cell therapies; Pluripotent stem cell therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Macular degeneration
Most Recent Events
- 01 Jun 2023 Preclinical trials in Macular degeneration in South Korea (Parenteral) prior to June 2023 (S.Biomedics pipeline, June 2023)